Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation

This study sought to perform an indirect comparison analysis of dabigatran etexilate (2 doses), rivaroxaban, and apixaban for their relative efficacy and safety against each other. Data for warfarin compared against the new oral anticoagulants (OACs) in large phase III clinical trials of stroke prev...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology Jg. 60; H. 8; S. 738
Hauptverfasser:	Lip, Gregory Y H, Larsen, Torben Bjerregaard, Skjøth, Flemming, Rasmussen, Lars Hvilsted
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 21.08.2012
Schlagworte:	Administration, Oral Aged Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - therapeutic use Atrial Fibrillation - complications Benzimidazoles - administration & dosage Benzimidazoles - adverse effects Benzimidazoles - therapeutic use Clinical Trials, Phase III as Topic Dabigatran Female Hemorrhage - chemically induced Humans Male Middle Aged Morpholines - administration & dosage Morpholines - adverse effects Morpholines - therapeutic use Odds Ratio Pyrazoles - administration & dosage Pyrazoles - adverse effects Pyrazoles - therapeutic use Pyridines - administration & dosage Pyridines - adverse effects Pyridines - therapeutic use Pyridones - administration & dosage Pyridones - adverse effects Pyridones - therapeutic use Rivaroxaban Stroke - etiology Stroke - prevention & control Thiophenes - administration & dosage Thiophenes - adverse effects Thiophenes - therapeutic use Treatment Outcome
ISSN:	1558-3597, 1558-3597
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!